Research Library — Therapeutic Applications | Reta Compare
18 research articles in Therapeutic Applications. Page 1 of 1.
Articles
- Quad-Agonist GLP Drugs for Severe Obesity: Future Perspectives
- Quad-Agonist GLP Drugs for Type 2 Diabetes and Heart Failure
- Quad-Agonist GLP Drugs for MASH/NASH: Targeting Liver Disease
- Quad-Agonist GLP Drugs for Sleep Apnea
- Quad-Agonist GLP Drugs for Polycystic Ovary Syndrome (PCOS)
- Quad-Agonist GLP Drugs for Alzheimer's and Cognitive Decline
- Exploring Quad-Agonist GLP Drugs for Addiction and Reward Pathways
- Quad-Agonist GLP Drugs for Sarcopenic Obesity in Older Adults
- Quad-Agonist GLP Drugs for Pediatric Obesity: Future Perspectives
- Quad-Agonist GLP Drugs for Chronic Kidney Disease
- Quad-Agonist GLP Drugs for Atherosclerotic Cardiovascular Disease
- Quad-Agonist GLP Drugs for Pre-Diabetes Prevention
- Quad-Agonist GLP Drugs for Severe Insulin Resistance Syndromes
- Quad-Agonist GLP Drugs for Hypothalamic Obesity
- Quad-Agonist GLP Drugs for Lipodystrophy: A Forward-Looking Analysis
- Quad-Agonist GLP Drugs for Metabolic Syndrome
- Exploring Quad-Agonist GLP Drugs and Bone Health: GIP Receptor Considerations
- Quad-Agonist GLP Drugs for Long-Term Weight Maintenance After Bariatric Surgery